F.D.A. Approves Moderna’s mRNA Flu Vaccine
First publishedAug 5, 08:43 UTC
Last updatedAug 6, 04:56 UTC · 2m ago
1 outlet
NPR Health1 outletNPR News1 outletNPR Health2 outlets
NYT Business, NBC News2 outlets
CBS News, ABC News
7 outlets over time — hover a bar for its window & outletslast updated
Answer
Moderna has said that the faster new approach used to prepare the vaccine will enable a shift away from the current process of focusing on one flu strain for an entire hemisphere each season and allow each nation to pick its best option.
Reported by 7 outlets — NYT Business, NPR News, ABC News, CBS News, NBC News, and 1 more. See all sources ↓
Read the full report at NYT Business ↗
Why it matters
7 outlets are covering this world story — one to watch as reporting develops.
In brief
- What's the story?
- Moderna has said that the faster new approach used to prepare the vaccine will enable a shift away from the current process of focusing on one flu strain for an entire hemisphere each season and allow each nation to pick its best option.
- How widely is it covered?
- 7 outlets, average source rating 8.3/10.
- When was it last updated?
- 2m ago.
Different angles across outlets
Coverage map
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card6 outlets1CoverageScouting report
U.S. missile stockpiles dwindle. And, FDA weighs approval of flu shots with mRNA tech
Sources6TypeCoverage
Related in the knowledge graph
Sources (7)
Avg source rating 8.3/10Processing cluster
A1A2A3B1B2B3